rs146709578
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004260.4(RECQL4):c.716C>T(p.Ala239Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00223 in 1,609,550 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00125 AC: 190AN: 152228Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00106 AC: 257AN: 242476Hom.: 2 AF XY: 0.00106 AC XY: 141AN XY: 132714
GnomAD4 exome AF: 0.00233 AC: 3399AN: 1457204Hom.: 10 Cov.: 35 AF XY: 0.00229 AC XY: 1661AN XY: 724866
GnomAD4 genome AF: 0.00125 AC: 190AN: 152346Hom.: 0 Cov.: 34 AF XY: 0.00123 AC XY: 92AN XY: 74502
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:5
- -
This variant is associated with the following publications: (PMID: 24728327) -
The RECQL4 p.Ala239Val variant was not identified in Cosmic but was identified in dbSNP (ID: rs146709578), LOVD 3.0 and ClinVar (reported benign for Baller-Gerold syndrome by Invitae and as a VUS by the Children's Hospital of Philadelphia Divison of Genomic Diagnostics). The variant was identified in control databases in 293 of 273858 chromosomes (2 homozygous) at a frequency of 0.00107 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: Other in 14 of 7024 chromosomes (freq: 0.001993), European (non-Finnish) in 241 of 125570 chromosomes (freq: 0.001919), Latino in 19 of 35140 chromosomes (freq: 0.000541), African in 10 of 23374 chromosomes (freq: 0.000428) and South Asian in 9 of 30398 chromosomes (freq: 0.000296); it was not observed in the Ashkenazi Jewish, East Asian, and European (Finnish) populations. The p.Ala239 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. This variant was identified in a study analyzing the prevalence of germline variants in cancer-susceptibility genes in a healthy population and was reported with a frequency of 0.0044 (Bodian_2014_PMID: 24728327). In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
- -
- -
RECQL4: BP1, BP4, BS2 -
not specified Uncertain:1Benign:1Other:1
- -
- -
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary cancer-predisposing syndrome Benign:1
- -
Baller-Gerold syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at